These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of piperacillin dose on elimination kinetics in renal impairment. Aronoff GR; Sloan RS; Brier ME; Luft FC Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908 [TBL] [Abstract][Full Text] [Related]
8. Piperacillin pharmacokinetics in subjects with chronic renal failure. Thompson MI; Russo ME; Matsen JM; Atkin-Thor E Antimicrob Agents Chemother; 1981 Mar; 19(3):450-3. PubMed ID: 6454382 [TBL] [Abstract][Full Text] [Related]
9. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. Tjandramaga TB; Mullie A; Verbesselt R; De Schepper PJ; Verbist L Antimicrob Agents Chemother; 1978 Dec; 14(6):829-37. PubMed ID: 742871 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Meyers BR; Hirschman SZ; Strougo L; Srulevitch E Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function. Brogard JM; Comte F; Spach MO; Lavillaureix J Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis. Francke EL; Appel GB; Neu HC Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260 [TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children. Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function. Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418 [TBL] [Abstract][Full Text] [Related]
15. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
17. Cefmenoxime pharmacokinetics in patients with renal insufficiency. Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of temocillin in patients with normal and impaired renal function. Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment. Derendorf H; Dalla Costa T Int J Clin Pharmacol Ther; 1996 Nov; 34(11):482-8. PubMed ID: 8937930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]